Eating Disorders Trial, Recruiting NCT06043154 Sponsor: Nantes University Hospital Condition: Eating Disorders
Back to Eating Disorders

Eating Disorders Trial, Recruiting

NCT06043154
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be a woman
  • You must be older than 15 years and 3 months
  • You must be admitted to the eating disorders specialist unit at CHU Nantes hospital for a refeeding programme
  • You must have been diagnosed with anorexia nervosa (either the restrictive type or the binge-eating/purging type) at the time of admission
  • Your Body Mass Index (BMI) must be below 16 at the time of admission
  • If you are 18 or older, you must be able to give written consent to take part; if you are under 18, both you and your legal guardian must give consent
  • You must be covered by, or a dependent of someone covered by, the French social security system

Who may not be able to join:

  • You are currently pregnant or breastfeeding
  • You have taken antibiotic or antifungal medication (not including creams or other products applied to the skin) in the last three months
  • You have gained 5% or more of your admission body weight in the month before joining the trial
  • You are under a legal protection order such as trusteeship or guardianship (confirm with trial site)
  • You are not fluent in French
  • You are already taking part in another clinical trial that involves a medication or treatment
  • It would not be possible to collect a stool sample or complete a body composition scan (a type of low-dose X-ray called a DEXA scan) within your first week in hospital

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +33 2 40 84 76 20

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
22 February 2024
Est. completion
30 September 2028

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Identification of gut microbiota biomarkers - composition; Identification of gut microbiota biomarkers - diversity and richness; Identification of gut microbiota biomarkers - metabolites

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov